Roche's triplet involving Tecentriq clears the PFS bar for melanoma when added to BRAF/MEK combo
In a “check the box” exercise, Roche said it has shown that adding Tecentriq to a combo of Cotellic and Zelboraf was effective in extending …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
